APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Prevention

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Flu Prevention Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchFlu Prevention Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Prevention Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Flu Prevention Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Prevention Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Prevention Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Flu Prevention market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flu Prevention is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Flu Prevention is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Flu Prevention is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Flu Prevention is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Flu Prevention include AstraZeneca, BCHT, CSL, KM Biologics, Sinovac, GSK, Hualan Bio, Viatris and Jiangsu GDK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flu Prevention, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flu Prevention, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Prevention, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Prevention sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flu Prevention market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flu Prevention sales, projected growth trends, production technology, application and end-user industry.

Flu Prevention Segment by Company

AstraZeneca

BCHT

CSL

KM Biologics

Sinovac

GSK

Hualan Bio

Viatris

Jiangsu GDK

Sanofi

Changchun Institute of Biological

Flu Prevention Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Flu Prevention Segment by Application

6 Months to 3 Years

> 3 Years

Flu Prevention Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Prevention market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Prevention and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Prevention.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flu Prevention in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flu Prevention manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Prevention sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flu Prevention Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Trivalent Influenza Vaccine Major Manufacturers Table 3. Quadrivalent Influenza Vaccine Major Manufacturers Table 4. Global Flu Prevention Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. 6 Months to 3 Years Major Manufacturers Table 6. > 3 Years Major Manufacturers Table 7. Flu Prevention Industry Trends Table 8. Flu Prevention Industry Drivers Table 9. Flu Prevention Industry Opportunities and Challenges Table 10. Flu Prevention Industry Restraints Table 11. Global Flu Prevention Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Flu Prevention Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Flu Prevention Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Flu Prevention Revenue Market Share by Region (2021-2026) Table 15. Global Flu Prevention Revenue Market Share by Region (2027-2032) Table 16. Global Flu Prevention Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Flu Prevention Sales by Region (2021-2026) & (M Doses) Table 18. Global Flu Prevention Sales by Region (2027-2032) & (M Doses) Table 19. Global Flu Prevention Sales Market Share by Region (2021-2026) Table 20. Global Flu Prevention Sales Market Share by Region (2027-2032) Table 21. Global Flu Prevention Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Flu Prevention Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Flu Prevention Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Flu Prevention Sales Market Share by Manufacturers (2021-2026) Table 25. Global Flu Prevention Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Flu Prevention Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Flu Prevention Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Flu Prevention Manufacturers, Product Type & Application Table 29. Global Flu Prevention Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Flu Prevention by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Flu Prevention Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Flu Prevention Revenue Market Share by Type (2021-2026) Table 36. Global Flu Prevention Revenue Market Share by Type (2027-2032) Table 37. Global Flu Prevention Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 39. Global Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 40. Global Flu Prevention Sales Market Share by Type (2021-2026) Table 41. Global Flu Prevention Sales Market Share by Type (2027-2032) Table 42. Global Flu Prevention Price by Type (2021-2026) & (US$/Unit) Table 43. Global Flu Prevention Price by Type (2027-2032) & (US$/Unit) Table 44. Global Flu Prevention Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Flu Prevention Revenue Market Share by Application (2021-2026) Table 48. Global Flu Prevention Revenue Market Share by Application (2027-2032) Table 49. Global Flu Prevention Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 51. Global Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 52. Global Flu Prevention Sales Market Share by Application (2021-2026) Table 53. Global Flu Prevention Sales Market Share by Application (2027-2032) Table 54. Global Flu Prevention Price by Application (2021-2026) & (US$/Unit) Table 55. Global Flu Prevention Price by Application (2027-2032) & (US$/Unit) Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. AstraZeneca Flu Prevention Product Portfolio Table 60. AstraZeneca Recent Development Table 61. BCHT Company Information Table 62. BCHT Business Overview Table 63. BCHT Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. BCHT Flu Prevention Product Portfolio Table 65. BCHT Recent Development Table 66. CSL Company Information Table 67. CSL Business Overview Table 68. CSL Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. CSL Flu Prevention Product Portfolio Table 70. CSL Recent Development Table 71. KM Biologics Company Information Table 72. KM Biologics Business Overview Table 73. KM Biologics Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. KM Biologics Flu Prevention Product Portfolio Table 75. KM Biologics Recent Development Table 76. Sinovac Company Information Table 77. Sinovac Business Overview Table 78. Sinovac Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sinovac Flu Prevention Product Portfolio Table 80. Sinovac Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Flu Prevention Product Portfolio Table 85. GSK Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hualan Bio Flu Prevention Product Portfolio Table 90. Hualan Bio Recent Development Table 91. Viatris Company Information Table 92. Viatris Business Overview Table 93. Viatris Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Viatris Flu Prevention Product Portfolio Table 95. Viatris Recent Development Table 96. Jiangsu GDK Company Information Table 97. Jiangsu GDK Business Overview Table 98. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu GDK Flu Prevention Product Portfolio Table 100. Jiangsu GDK Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi Flu Prevention Product Portfolio Table 105. Sanofi Recent Development Table 106. Changchun Institute of Biological Company Information Table 107. Changchun Institute of Biological Business Overview Table 108. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Changchun Institute of Biological Flu Prevention Product Portfolio Table 110. Changchun Institute of Biological Recent Development Table 111. North America Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 114. North America Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 115. North America Flu Prevention Sales Price by Type (2021-2026) & (US$/Unit) Table 116. North America Flu Prevention Sales Price by Type (2027-2032) & (US$/Unit) Table 117. North America Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 120. North America Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 121. North America Flu Prevention Sales Price by Application (2021-2026) & (US$/Unit) Table 122. North America Flu Prevention Sales Price by Application (2027-2032) & (US$/Unit) Table 123. North America Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Flu Prevention Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Flu Prevention Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Flu Prevention Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 127. North America Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 128. North America Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 129. North America Flu Prevention Sales Price by Country (2021-2026) & (US$/Unit) Table 130. North America Flu Prevention Sales Price by Country (2027-2032) & (US$/Unit) Table 131. United States Flu Prevention Revenue (2021-2032) & (US$ Million) Table 132. Canada Flu Prevention Revenue (2021-2032) & (US$ Million) Table 133. Mexico Flu Prevention Revenue (2021-2032) & (US$ Million) Table 134. Europe Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 137. Europe Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 138. Europe Flu Prevention Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Flu Prevention Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 143. Europe Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 144. Europe Flu Prevention Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Flu Prevention Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Flu Prevention Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Flu Prevention Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Flu Prevention Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 150. Europe Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 151. Europe Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 152. Europe Flu Prevention Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Flu Prevention Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Flu Prevention Revenue (2021-2032) & (US$ Million) Table 155. France Flu Prevention Revenue (2021-2032) & (US$ Million) Table 156. U.K. Flu Prevention Revenue (2021-2032) & (US$ Million) Table 157. Italy Flu Prevention Revenue (2021-2032) & (US$ Million) Table 158. Russia Flu Prevention Revenue (2021-2032) & (US$ Million) Table 159. Spain Flu Prevention Revenue (2021-2032) & (US$ Million) Table 160. Netherlands Flu Prevention Revenue (2021-2032) & (US$ Million) Table 161. Switzerland Flu Prevention Revenue (2021-2032) & (US$ Million) Table 162. Sweden Flu Prevention Revenue (2021-2032) & (US$ Million) Table 163. Poland Flu Prevention Revenue (2021-2032) & (US$ Million) Table 164. China Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 165. China Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 166. China Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 167. China Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 168. China Flu Prevention Sales Price by Type (2021-2026) & (US$/Unit) Table 169. China Flu Prevention Sales Price by Type (2027-2032) & (US$/Unit) Table 170. China Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 171. China Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 172. China Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 173. China Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 174. China Flu Prevention Sales Price by Application (2021-2026) & (US$/Unit) Table 175. China Flu Prevention Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 179. Asia Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 180. Asia Flu Prevention Sales Price by Type (2021-2026) & (US$/Unit) Table 181. Asia Flu Prevention Sales Price by Type (2027-2032) & (US$/Unit) Table 182. Asia Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 185. Asia Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 186. Asia Flu Prevention Sales Price by Application (2021-2026) & (US$/Unit) Table 187. Asia Flu Prevention Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Flu Prevention Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Flu Prevention Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Flu Prevention Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 192. Asia Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 193. Asia Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 194. Asia Flu Prevention Sales Price by Country (2021-2026) & (US$/Unit) Table 195. Asia Flu Prevention Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Japan Flu Prevention Revenue (2021-2032) & (US$ Million) Table 197. South Korea Flu Prevention Revenue (2021-2032) & (US$ Million) Table 198. India Flu Prevention Revenue (2021-2032) & (US$ Million) Table 199. Australia Flu Prevention Revenue (2021-2032) & (US$ Million) Table 200. Taiwan Flu Prevention Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Flu Prevention Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Flu Prevention Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Flu Prevention Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 205. SAMEA Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 206. SAMEA Flu Prevention Sales Price by Type (2021-2026) & (US$/Unit) Table 207. SAMEA Flu Prevention Sales Price by Type (2027-2032) & (US$/Unit) Table 208. SAMEA Flu Prevention Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Flu Prevention Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 211. SAMEA Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 212. SAMEA Flu Prevention Sales Price by Application (2021-2026) & (US$/Unit) Table 213. SAMEA Flu Prevention Sales Price by Application (2027-2032) & (US$/Unit) Table 214. SAMEA Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Flu Prevention Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Flu Prevention Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Flu Prevention Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 218. SAMEA Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 219. SAMEA Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 220. SAMEA Flu Prevention Sales Price by Country (2021-2026) & (US$/Unit) Table 221. SAMEA Flu Prevention Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Brazil Flu Prevention Revenue (2021-2032) & (US$ Million) Table 223. Argentina Flu Prevention Revenue (2021-2032) & (US$ Million) Table 224. Chile Flu Prevention Revenue (2021-2032) & (US$ Million) Table 225. Colombia Flu Prevention Revenue (2021-2032) & (US$ Million) Table 226. Peru Flu Prevention Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Flu Prevention Revenue (2021-2032) & (US$ Million) Table 228. Israel Flu Prevention Revenue (2021-2032) & (US$ Million) Table 229. UAE Flu Prevention Revenue (2021-2032) & (US$ Million) Table 230. Turkey Flu Prevention Revenue (2021-2032) & (US$ Million) Table 231. Iran Flu Prevention Revenue (2021-2032) & (US$ Million) Table 232. Egypt Flu Prevention Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Flu Prevention Distributors List Table 236. Flu Prevention Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Flu Prevention Image Figure 2. Global Flu Prevention Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Prevention Market Size Share 2021 VS 2025 VS 2032 Figure 4. Trivalent Influenza Vaccine Image Figure 5. Quadrivalent Influenza Vaccine Image Figure 6. Global Flu Prevention Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Flu Prevention Market Size Share 2021 VS 2025 VS 2032 Figure 8. 6 Months to 3 Years Image Figure 9. > 3 Years Image Figure 10. Global Flu Prevention Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Flu Prevention Revenue (2021-2032) & (US$ Million) Figure 12. Global Flu Prevention Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Flu Prevention Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Flu Prevention Revenue Market Share by Region (2021-2032) Figure 15. Global Flu Prevention Sales (2021-2032) & (M Doses) Figure 16. Global Flu Prevention Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Flu Prevention Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Flu Prevention Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Flu Prevention Sales YoY (2021-2032) & (M Doses) Figure 20. China Flu Prevention Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Flu Prevention Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Flu Prevention Sales YoY (2021-2032) & (M Doses) Figure 23. Global Flu Prevention Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Flu Prevention Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Flu Prevention Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Flu Prevention Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Flu Prevention Revenue Market Share by Type (2021-2032) Figure 29. Global Flu Prevention Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Flu Prevention Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Flu Prevention Sales Market Share by Type (2021-2032) Figure 32. Global Flu Prevention Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Flu Prevention Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Flu Prevention Revenue Market Share by Application (2021-2032) Figure 35. Global Flu Prevention Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Flu Prevention Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Flu Prevention Sales Market Share by Application (2021-2032) Figure 38. North America Flu Prevention Revenue Share by Type (2021-2032) Figure 39. North America Flu Prevention Sales Share by Type (2021-2032) Figure 40. North America Flu Prevention Revenue Share by Application (2021-2032) Figure 41. North America Flu Prevention Sales Share by Application (2021-2032) Figure 42. North America Flu Prevention Revenue Share by Country (2021-2032) Figure 43. North America Flu Prevention Sales Share by Country (2021-2032) Figure 44. Europe Flu Prevention Revenue Share by Type (2021-2032) Figure 45. Europe Flu Prevention Sales Share by Type (2021-2032) Figure 46. Europe Flu Prevention Revenue Share by Application (2021-2032) Figure 47. Europe Flu Prevention Sales Share by Application (2021-2032) Figure 48. Europe Flu Prevention Revenue Share by Country (2021-2032) Figure 49. Europe Flu Prevention Sales Share by Country (2021-2032) Figure 50. China Flu Prevention Revenue Share by Type (2021-2032) Figure 51. China Flu Prevention Sales Share by Type (2021-2032) Figure 52. China Flu Prevention Revenue Share by Application (2021-2032) Figure 53. China Flu Prevention Sales Share by Application (2021-2032) Figure 54. Asia Flu Prevention Revenue Share by Type (2021-2032) Figure 55. Asia Flu Prevention Sales Share by Type (2021-2032) Figure 56. Asia Flu Prevention Revenue Share by Application (2021-2032) Figure 57. Asia Flu Prevention Sales Share by Application (2021-2032) Figure 58. Asia Flu Prevention Revenue Share by Country (2021-2032) Figure 59. Asia Flu Prevention Sales Share by Country (2021-2032) Figure 60. SAMEA Flu Prevention Revenue Share by Type (2021-2032) Figure 61. SAMEA Flu Prevention Sales Share by Type (2021-2032) Figure 62. SAMEA Flu Prevention Revenue Share by Application (2021-2032) Figure 63. SAMEA Flu Prevention Sales Share by Application (2021-2032) Figure 64. SAMEA Flu Prevention Revenue Share by Country (2021-2032) Figure 65. SAMEA Flu Prevention Sales Share by Country (2021-2032) Figure 66. Flu Prevention Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Flu Prevention Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Applications
  • 6 Months to 3 Years
  • > 3 Years
Companies covered
  • AstraZeneca
  • BCHT
  • CSL
  • KM Biologics
  • Sinovac
  • GSK
  • Hualan Bio
  • Viatris
  • Jiangsu GDK
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flu Prevention Market by Type
  3. 1.2.1 Global Flu Prevention Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Trivalent Influenza Vaccine
  5. 1.2.3 Quadrivalent Influenza Vaccine
  6. 1.3 Flu Prevention Market by Application
  7. 1.3.1 Global Flu Prevention Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 6 Months to 3 Years
  9. 1.3.3 > 3 Years
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Flu Prevention Market Dynamics
  1. 2.1 Flu Prevention Industry Trends
  2. 2.2 Flu Prevention Industry Drivers
  3. 2.3 Flu Prevention Industry Opportunities and Challenges
  4. 2.4 Flu Prevention Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flu Prevention Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flu Prevention Revenue by Region
  3. 3.2.1 Global Flu Prevention Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flu Prevention Revenue by Region (2021-2026)
  5. 3.2.3 Global Flu Prevention Revenue by Region (2027-2032)
  6. 3.2.4 Global Flu Prevention Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flu Prevention Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flu Prevention Sales by Region
  9. 3.4.1 Global Flu Prevention Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flu Prevention Sales by Region (2021-2026)
  11. 3.4.3 Global Flu Prevention Sales by Region (2027-2032)
  12. 3.4.4 Global Flu Prevention Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flu Prevention Revenue by Manufacturers
  2. 4.1.1 Global Flu Prevention Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flu Prevention Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flu Prevention Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flu Prevention Sales by Manufacturers
  6. 4.2.1 Global Flu Prevention Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flu Prevention Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flu Prevention Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flu Prevention Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flu Prevention Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flu Prevention Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flu Prevention Manufacturers, Product Type & Application
  13. 4.7 Global Flu Prevention Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flu Prevention Market CR5 and HHI
  16. 4.8.2 2025 Flu Prevention Tier 1, Tier 2, and Tier 3
5 Flu Prevention Market by Type
  1. 5.1 Global Flu Prevention Revenue by Type
  2. 5.1.1 Global Flu Prevention Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flu Prevention Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flu Prevention Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flu Prevention Sales by Type
  6. 5.2.1 Global Flu Prevention Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flu Prevention Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Flu Prevention Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flu Prevention Price by Type
6 Flu Prevention Market by Application
  1. 6.1 Global Flu Prevention Revenue by Application
  2. 6.1.1 Global Flu Prevention Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flu Prevention Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flu Prevention Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flu Prevention Sales by Application
  6. 6.2.1 Global Flu Prevention Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flu Prevention Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Flu Prevention Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flu Prevention Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Flu Prevention Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 BCHT
  8. 7.2.1 BCHT Company Information
  9. 7.2.2 BCHT Business Overview
  10. 7.2.3 BCHT Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 BCHT Flu Prevention Product Portfolio
  12. 7.2.5 BCHT Recent Developments
  13. 7.3 CSL
  14. 7.3.1 CSL Company Information
  15. 7.3.2 CSL Business Overview
  16. 7.3.3 CSL Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Flu Prevention Product Portfolio
  18. 7.3.5 CSL Recent Developments
  19. 7.4 KM Biologics
  20. 7.4.1 KM Biologics Company Information
  21. 7.4.2 KM Biologics Business Overview
  22. 7.4.3 KM Biologics Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 KM Biologics Flu Prevention Product Portfolio
  24. 7.4.5 KM Biologics Recent Developments
  25. 7.5 Sinovac
  26. 7.5.1 Sinovac Company Information
  27. 7.5.2 Sinovac Business Overview
  28. 7.5.3 Sinovac Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sinovac Flu Prevention Product Portfolio
  30. 7.5.5 Sinovac Recent Developments
  31. 7.6 GSK
  32. 7.6.1 GSK Company Information
  33. 7.6.2 GSK Business Overview
  34. 7.6.3 GSK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GSK Flu Prevention Product Portfolio
  36. 7.6.5 GSK Recent Developments
  37. 7.7 Hualan Bio
  38. 7.7.1 Hualan Bio Company Information
  39. 7.7.2 Hualan Bio Business Overview
  40. 7.7.3 Hualan Bio Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Bio Flu Prevention Product Portfolio
  42. 7.7.5 Hualan Bio Recent Developments
  43. 7.8 Viatris
  44. 7.8.1 Viatris Company Information
  45. 7.8.2 Viatris Business Overview
  46. 7.8.3 Viatris Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Viatris Flu Prevention Product Portfolio
  48. 7.8.5 Viatris Recent Developments
  49. 7.9 Jiangsu GDK
  50. 7.9.1 Jiangsu GDK Company Information
  51. 7.9.2 Jiangsu GDK Business Overview
  52. 7.9.3 Jiangsu GDK Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jiangsu GDK Flu Prevention Product Portfolio
  54. 7.9.5 Jiangsu GDK Recent Developments
  55. 7.10 Sanofi
  56. 7.10.1 Sanofi Company Information
  57. 7.10.2 Sanofi Business Overview
  58. 7.10.3 Sanofi Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Flu Prevention Product Portfolio
  60. 7.10.5 Sanofi Recent Developments
  61. 7.11 Changchun Institute of Biological
  62. 7.11.1 Changchun Institute of Biological Company Information
  63. 7.11.2 Changchun Institute of Biological Business Overview
  64. 7.11.3 Changchun Institute of Biological Flu Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Changchun Institute of Biological Flu Prevention Product Portfolio
  66. 7.11.5 Changchun Institute of Biological Recent Developments
8 North America
  1. 8.1 North America Flu Prevention Market Size by Type
  2. 8.1.1 North America Flu Prevention Revenue by Type (2021-2032)
  3. 8.1.2 North America Flu Prevention Sales by Type (2021-2032)
  4. 8.1.3 North America Flu Prevention Price by Type (2021-2032)
  5. 8.2 North America Flu Prevention Market Size by Application
  6. 8.2.1 North America Flu Prevention Revenue by Application (2021-2032)
  7. 8.2.2 North America Flu Prevention Sales by Application (2021-2032)
  8. 8.2.3 North America Flu Prevention Price by Application (2021-2032)
  9. 8.3 North America Flu Prevention Market Size by Country
  10. 8.3.1 North America Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flu Prevention Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flu Prevention Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Flu Prevention Market Size by Type
  2. 9.1.1 Europe Flu Prevention Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flu Prevention Sales by Type (2021-2032)
  4. 9.1.3 Europe Flu Prevention Price by Type (2021-2032)
  5. 9.2 Europe Flu Prevention Market Size by Application
  6. 9.2.1 Europe Flu Prevention Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flu Prevention Sales by Application (2021-2032)
  8. 9.2.3 Europe Flu Prevention Price by Application (2021-2032)
  9. 9.3 Europe Flu Prevention Market Size by Country
  10. 9.3.1 Europe Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flu Prevention Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flu Prevention Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Flu Prevention Market Size by Type
  2. 10.1.1 China Flu Prevention Revenue by Type (2021-2032)
  3. 10.1.2 China Flu Prevention Sales by Type (2021-2032)
  4. 10.1.3 China Flu Prevention Price by Type (2021-2032)
  5. 10.2 China Flu Prevention Market Size by Application
  6. 10.2.1 China Flu Prevention Revenue by Application (2021-2032)
  7. 10.2.2 China Flu Prevention Sales by Application (2021-2032)
  8. 10.2.3 China Flu Prevention Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flu Prevention Market Size by Type
  2. 11.1.1 Asia Flu Prevention Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flu Prevention Sales by Type (2021-2032)
  4. 11.1.3 Asia Flu Prevention Price by Type (2021-2032)
  5. 11.2 Asia Flu Prevention Market Size by Application
  6. 11.2.1 Asia Flu Prevention Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flu Prevention Sales by Application (2021-2032)
  8. 11.2.3 Asia Flu Prevention Price by Application (2021-2032)
  9. 11.3 Asia Flu Prevention Market Size by Country
  10. 11.3.1 Asia Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flu Prevention Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flu Prevention Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flu Prevention Market Size by Type
  2. 12.1.1 SAMEA Flu Prevention Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flu Prevention Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flu Prevention Price by Type (2021-2032)
  5. 12.2 SAMEA Flu Prevention Market Size by Application
  6. 12.2.1 SAMEA Flu Prevention Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flu Prevention Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flu Prevention Price by Application (2021-2032)
  9. 12.3 SAMEA Flu Prevention Market Size by Country
  10. 12.3.1 SAMEA Flu Prevention Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flu Prevention Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flu Prevention Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flu Prevention Value Chain Analysis
  2. 13.1.1 Flu Prevention Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flu Prevention Production Mode & Process
  6. 13.2 Flu Prevention Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flu Prevention Distributors
  9. 13.2.3 Flu Prevention Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst